摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 1588776-73-1

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
1588776-73-1
化学式
C22H27NO2
mdl
——
分子量
337.462
InChiKey
QGCSDJQPXNOVHF-NBVRZTHBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.03
  • 重原子数:
    25.0
  • 可旋转键数:
    8.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    38.33
  • 氢给体数:
    1.0
  • 氢受体数:
    2.0

反应信息

  • 作为反应物:
    描述:
    在 lithium aluminium tetrahydride 、 ammonium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 10.33h, 以60%的产率得到(E)-3,7-dimethyl-N-(2-(naphthalen-1-yloxy)ethyl)octa-2,6-dien-1-amine
    参考文献:
    名称:
    Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
    摘要:
    We report the discovery of a series of new drug leads that have potent activity against Mycobacterium tuberculosis as well as against other bacteria, fungi, and a malaria parasite. The compounds are analogues of the new tuberculosis (TB) drug SQ109 (1), which has been reported to act by inhibiting a transporter called MmpL3, involved in cell wall biosynthesis. We show that 1 and the new compounds also target enzymes involved in menaquinone biosynthesis and electron transport, inhibiting respiration and ATP biosynthesis, and are uncouplers, collapsing the pH gradient and membrane potential used to power transporters. The result of such multitarget inhibition is potent inhibition of TB cell growth, as well as very low rates of spontaneous drug resistance. Several targets are absent in humans but are present in other bacteria, as well as in malaria parasites, whose growth is also inhibited.
    DOI:
    10.1021/jm500131s
  • 作为产物:
    描述:
    香叶胺四丁基硫酸氢铵 、 sodium hydride 、 potassium carbonate 作用下, 以 四氢呋喃氯仿 为溶剂, 反应 16.5h, 生成
    参考文献:
    名称:
    Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
    摘要:
    We report the discovery of a series of new drug leads that have potent activity against Mycobacterium tuberculosis as well as against other bacteria, fungi, and a malaria parasite. The compounds are analogues of the new tuberculosis (TB) drug SQ109 (1), which has been reported to act by inhibiting a transporter called MmpL3, involved in cell wall biosynthesis. We show that 1 and the new compounds also target enzymes involved in menaquinone biosynthesis and electron transport, inhibiting respiration and ATP biosynthesis, and are uncouplers, collapsing the pH gradient and membrane potential used to power transporters. The result of such multitarget inhibition is potent inhibition of TB cell growth, as well as very low rates of spontaneous drug resistance. Several targets are absent in humans but are present in other bacteria, as well as in malaria parasites, whose growth is also inhibited.
    DOI:
    10.1021/jm500131s
点击查看最新优质反应信息